A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk

@article{Koh2007ACO,
  title={A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk},
  author={E Koh and Tu Huan Tran and Mostafa Heydarian and Rainer K. Sachs and Richard Tsang and David J. Brenner and Melania Pintilie and Tony Xu and June Key Chung and Narinder Paul and D. C. Hodgson},
  journal={Radiation Oncology (London, England)},
  year={2007},
  volume={2},
  pages={13 - 13}
}
BACKGROUND Hodgkin's lymphoma (HL) survivors who undergo radiotherapy experience increased risks of second cancers (SC) and cardiac sequelae. To reduce such risks, extended-field radiotherapy (RT) for HL has largely been replaced by involved field radiotherapy (IFRT). While it has generally been assumed that IFRT will reduce SC risks, there are few data that quantify the reduction in dose to normal tissues associated with modern RT practice for patients with mediastinal HL, and no estimates of… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 48 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 36 references

Radiation Field Design and Dose in Hodgkin's Disease and Non-Hodgkin's Lymphoma:New Concepts, New Tools.

  • J Yahalom
  • 2004
Highly Influential
5 Excerpts

Similar Papers

Loading similar papers…